
Danaher Corporation
DHRDanaher Corporation (DHR) is a global science and technology innovator that designs, manufactures, and markets professional, medical, industrial, and consumer products and services. Founded in 1984, the company operates through various segments, including life sciences, diagnostics, and environmental & applied solutions, serving customers in health, environmental, and industrial markets worldwide. Danaher is known for its focus on continuous improvement and leveraging science and technology to solve complex problems.
Dividend History
Investors can expect a dividend payout of $0.40 per share, scheduled to be distributed in 13 days on July 31, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 31, 2026 | $0.40 | 2026-06-26 | 2026-06-26 |
| April 24, 2026 | $0.40 | 2026-03-27 | 2026-03-27 |
| January 30, 2026 | $0.32 | 2025-12-26 | 2025-12-26 |
| October 31, 2025 | $0.32 | 2025-09-26 | 2025-09-26 |
| July 25, 2025 | $0.32 | 2025-06-27 | 2025-06-27 |
Dividends Summary
- Consistent Payer: Danaher Corporation has rewarded shareholders with 91 dividend payments over the past 22 years.
- Total Returned Value: Investors who held DHR shares during this period received a total of $11.15 per share in dividend income.
- Latest Payout: The most recent dividend of $0.40/share was paid 85 days ago, on April 24, 2026.
- Yield & Schedule: DHR currently pays dividends quarterly with an annual yield of 0.71%.
- Dividend Growth: Since 2004, the dividend payout has grown by 1500.0%, from $0.03 to $0.40.
- Dividend Reliability: DHR has maintained or increased its dividend for 11 consecutive payments.
Company News
The global biochemistry analyzer market is projected to reach $8.18 billion by 2035, driven by increasing diagnostic testing demand, adoption of fully automated systems, artificial intelligence integration, and rising preventive screening programs. The market encompasses various product types, modalities, and applications across hospitals, diagno...
The global molecular biology enzymes, reagents and kits market is projected to grow from USD 27.69 billion in 2025 to USD 70.85 billion by 2035, with a CAGR of 9.68%. Growth is driven by increasing adoption of precision medicine, molecular diagnostics, genomics research, and biotechnology R&D. The US market is expected to reach $23.54 billion and...
The global spatial genomics and transcriptomics market is projected to grow from USD 0.60 billion in 2025 to USD 1.90 billion by 2035 at a 12.23% CAGR. Growth is driven by increased adoption of AI-powered spatial biology technologies, precision medicine initiatives, and high-resolution molecular profiling in oncology and translational research. N...
The global Oxidative Stress Assay Market is projected to grow at a CAGR of 9.53% from 2026 to 2035, driven by rising chronic disease prevalence, pharmaceutical R&D investments, and advancements in biomarker diagnostics. North America leads with 38.52% market share, while Asia-Pacific is expected to show the highest growth rate at 10.55%. ELISA te...
Bio-Techne shares surged 20% after Merck KGaA announced a $73-per-share cash acquisition offer. The deal comes one week after activist investor Ananym Capital Management built a stake and pushed for a sale. Trading volume reached 51.3M shares, significantly above average. Merck KGaA expects to achieve over $150 million in annual cost synergies wi...








